Numerous investigations demonstrated the alteration in expression of several cyclins, Cdks and the effects of several inhibitors of Cdks in experimental models of AD and in AD brain, but up till now no information exists on cD2 and cD1, cD3 in AD [45–50]. This evidence concerns the gene CD2 and Alzheimer disease.